We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

36 hedge funds and large institutions have $148M invested in Tango Therapeutics in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $150M → $148M (-$2.13M)

1.46% less ownership

Funds ownership: 63.87% → 62.41% (-1.5%)

8% less funds holding

Funds holding: 39 → 36 (-3)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
4
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.73M
2
HM
HealthCor Management
New York
+$472K
3
BFM
Boothbay Fund Management
New York
+$207K
4
DCM
Driehaus Capital Management
Illinois
+$117K
5
UBS Group
UBS Group
Switzerland
+$19K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.73M
2
SCM
Suvretta Capital Management
New York
-$1.14M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.12M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$663K
5
KSCM
Kamunting Street Capital Management
Florida
-$549K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Altium Capital Management
New York
$1.33M – – –
AAA
27
Affinity Asset Advisors
New York
$1.11M – – –
Millennium Management
28
Millennium Management
New York
$892K -$1.73M -150,760 -65%
Janus Henderson Group
29
Janus Henderson Group
United Kingdom
$834K -$1.12M -97,563 -56%
HM
30
HealthCor Management
New York
$456K +$472K +41,032 New
BFM
31
Boothbay Fund Management
New York
$375K +$207K +17,978 +114%
AW
32
Alaethes Wealth
Nevada
$222K +$230K +20,000 New
HF
33
HRT Financial
New York
$155K – – –
PAM
34
Panagora Asset Management
Massachusetts
$52K -$22.3K -1,936 -29%
UBS Group
35
UBS Group
Switzerland
$31K +$19K +1,651 +144%
SCM
36
Suvretta Capital Management
New York
– -$1.14M -100,000 Closed
KSCM
37
Kamunting Street Capital Management
Florida
– -$549K -48,000 Closed
CIM
38
Cowen Investment Management
New York
– -$286K -25,000 Closed
ECM
39
ExodusPoint Capital Management
New York
– -$114K -10,000 Closed
Wells Fargo
40
Wells Fargo
California
– -$98K -8,568 Closed
EAM
41
Exos Asset Management
New York
– -$13K -1,100 Closed
TRCT
42
Tower Research Capital (TRC)
New York
– +$196 +17 New
1
2

TNGX Hedge Fund Activity: Q1 2021 in Review

36 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q1 2021, worth a combined $148M — down 1.4% from $150M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TNGX and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Ikarian Capital, adding an estimated $1.73M. The largest seller was Millennium Management, cutting an estimated $1.73M.

  • 36 institutional investors held Tango Therapeutics (TNGX) as of Q1 2021, down from 39 in Q4 2020.
  • Funds reported $148M of Tango Therapeutics stock for Q1 2021, down 1.4% quarter-over-quarter.
  • 3 funds opened new Tango Therapeutics positions in Q1 2021 and 6 closed out, a net change of -3 holders.
  • The largest Tango Therapeutics buyer in Q1 2021 was Ikarian Capital, an estimated $1.73M added.
  • The largest Tango Therapeutics seller in Q1 2021 was Millennium Management, an estimated $1.73M sold.

Based on aggregated 13F filings for Q1 2021.